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Abstract
 
Assembly of T cell receptor (TCR)
 
 
 
/
 
  
 
genes by variable/diversity/joining (V[D]J) rearrange-
ment is an ordered process beginning with recombination activating gene (
 
RAG
 
) expression
and TCR
 
 
 
 recombination in CD4
 
 
 
CD8
 
 
 
CD25
 
 
 
 thymocytes. In these cells, TCR
 
 
 
 expres-
sion leads to clonal expansion, 
 
RAG
 
 downregulation, and TCR
 
 
 
 allelic exclusion. At the sub-
sequent CD4
 
 
 
CD8
 
 
 
 stage, 
 
RAG
 
 expression is reinduced and V(D)J recombination is initiated
at the TCR
 
 
 
 locus. This second wave of 
 
RAG
 
 expression is terminated upon expression of a
positively selected 
 
 
 
/
 
 
 
 TCR. To examine the physiologic role of the second wave of 
 
RAG
 
expression, we analyzed mice that cannot reinduce 
 
RAG
 
 expression in CD4
 
 
 
CD8
 
 
 
 T cells be-
cause the transgenic locus that directs 
 
RAG1
 
 and 
 
RAG2
 
 expression in these mice is missing a
distal regulatory element essential for reinduction. In the absence of 
 
RAG
 
 reinduction we find
normal numbers of CD4
 
 
 
CD8
 
 
 
 cells but a 50–70% reduction in the number of mature
CD4
 
 
 
CD8
 
 
 
 and CD4
 
 
 
CD8
 
 
 
 thymocytes. TCR
 
 
 
 rearrangement is restricted to the 5
 
 
 
 end of
the J
 
 
 
 cluster and there is little apparent secondary TCR
 
 
 
 recombination. Comparison of the
TCR
 
 
 
 genes expressed in wild-type or mutant mice shows that 65% of all 
 
 
 
/
 
 
 
 T cells carry
receptors that are normally assembled by secondary TCR
 
 
 
 rearrangement. We conclude that
 
RAG
 
 reinduction in CD4
 
 
 
CD8
 
 
 
 thymocytes is not required for initial TCR
 
 
 
 recombination
but is essential for secondary TCR
 
 
 
 recombination and that the majority of TCR
 
 
 
 chains ex-
pressed in mature T cells are products of secondary recombination.
 
Key words: T cell receptor 
 
 
 
 chain • gene rearrangement • regulation of gene expression • 
T cell receptor editing • recombination activating gene
 
Introduction
 
During lymphocyte development immunoglobulin and
TCR genes are assembled from germline V, D, and J gene
segments by a site-specific recombination reaction (1). The
V(D)J recombination reaction is mediated by the products of
the lymphocyte specific recombination activating genes
 
RAG1
 
*
 
 and 
 
RAG2 
 
which recognize and cleave recombina-
tion signal sequences located adjacent to the coding V, D, and
J segments (2–5). T and B lymphocyte development requires
 
V(D)J recombination; in the absence of RAG1
 
 
 
and RAG2
(6, 7) or factors that repair the double strand DNA breaks cre-
ated during V(D)J recombination there is a complete block in
the early stages of B and T cell development (8–15).
In thymocytes, V(D)J recombination is initiated at the
TCR
 
 
 
 locus in CD4
 
 
 
CD8
 
 
 
 double negative (DN) T cells
(16). Once a TCR
 
 
 
 chain is expressed it combines with
pre-T
 
 
 
 and CD3 components to produce the pre-TCR
complex (for reviews, see references 17 and 18). Pre-TCR
expression downregulates 
 
RAG
 
 expression and induces T
cells to mature to the CD4
 
 
 
CD8
 
 
 
 double positive (DP)
stage. Upon entering the DP stage there is a second wave
of 
 
RAG
 
 expression and V(D)J recombination (19–21).
Regulation of 
 
RAG
 
 expression in developing thymocytes
 
✪
 
The online version of this article contains supplemental material.
Address correspondence to Nikos Yannoutsos, The Rockefeller Uni-
versity, Box 220, 1230 York Ave., New York, NY 10021. Phone: 212-
327-8068; Fax: 212-327-8370; E-mail: yannoun@mail.rockefeller.edu
 
*
 
Abbreviations used in this paper:
 
 APC, allophycocyanin; BAC, bacterial
artificial chromosome; DN, double negative; DP, double positive; NBS,
Nijmegen breakage syndrome; SP, single positive; RAG, recombination
activating gene; RT, reverse transcription; TEA, T early 
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Role of 
 
RAG
 
 Reinduction in Thymocyte Development
 
has been studied by two groups (22, 23). Transgenic exper-
iments with large bacterial artificial chromosomes (BACs)
that carry fluorescent protein indicator genes in place of the
 
RAG
 
 genes, showed that a cis element 35–70 kb 5
 
 
 
 of
 
RAG2
 
 is required for the second wave of 
 
RAG
 
 expression
(22). However, 
 
RAG2
 
 
 
/
 
 
 
 blastocyst reconstitution experi-
ments indicated that T cell development could be rescued
with as little as 9 kb of sequence upstream of 
 
RAG2
 
 (23).
Thus, the cis requirements for 
 
RAG
 
 reinduction in DP
thymocytes and the functional consequences of reinduction
remain poorly defined.
In DP thymocytes V(D)J recombination is targeted to the
TCR
 
 
 
 locus. The TCR
 
 
 
/
 
 
 
 locus is a 1 megabase locus
that contains the 
 
 
 
 locus nested between the V
 
 
 
 and the J
 
 
 
segments; there are 61 J
 
 
 
 segments spread over 70 kb of
DNA (24–26). TCR
 
 
 
 recombination is believed to begin
at the 5
 
 
 
 end of the J
 
 
 
 cluster and progress to the 3
 
 
 
 J
 
 
 
s dur-
ing thymocyte maturation (27–29). This idea is indirectly
supported by the finding of sterile transcripts emanating
from the 5
 
 
 
 T early 
 
 
 
 promoter (TEA) in late DN thy-
mocytes (30, 31). Successful rearrangement and expression
of TCR
 
 
 
 genes is marked by an increase in cell surface
CD3/TCR levels, but expression of a TCR
 
 
 
/
 
 
 
 dimer is
not sufficient to turn off 
 
RAG
 
 expression and V(D)J recom-
bination. TCR
 
 
 
 recombination and 
 
RAG
 
 expression per-
sist until positive selection (32, 33). Continued TCR
 
 
 
 re-
combination in cells that express nonselected 
 
 
 
/
 
 
 
 TCRs
might result in absence of allelic exclusion, and could theo-
retically interfere with clonal selection (34). Persistent
recombination may nonetheless be advantageous if non-
selected or self-reactive receptors are replaced by useful re-
ceptors thereby salvaging thymocytes that would otherwise
be deleted. Indeed, in transgenic and gene targeted mice,
secondary TCR
 
 
 
 recombination efficiently replaces TCRs
that cannot be positively selected (20, 33, 35–37). Despite
the potential importance of secondary TCR
 
  
 
recombina-
tion for tolerance and repertoire diversification the extent to
which secondary recombination contributes to the TCR
repertoire in normal mice has not been determined.
Here we report on T cell development and TCR
 
 
 
 re-
combination in mice that are unable to upregulate RAG
expression in DP thymocytes. The results indicate that sec-
ondary V(D)J recombination makes a major contribution
to the normal TCR repertoire.
Materials and Methods
Mice. Clone m3e8A is an 80-kb yeast artificial chromosome
(YAC) containing the RAG1 and RAG2 genes (RYAC), identi-
fied by screening the YAC library of St. Mary’s Hospital Medical
School (38) with primers specific for RAG1 (Genethon). YAC
DNA was purified by pulsed field electrophoresis as described
(39), and microinjected into the pronuclei of fertilized ova of
RAG1 /   mice (129/SvxCD1 F1) (6). Transgenic founders
(RYII and RYIII) were bred for seven generations to C57Bl/6
RAG1 /  mice (The Jackson Laboratory). The single-copy line
RYII was also bred to RAG2 /  mice (Taconic Farms) (7). The
RAG2 /  TCR  mice were from Taconic Farms.
Flow Cytometry. Antibodies used were: PE anti-CD25, biotin
anti-CD44, fluorescein anti-CD3, PE–anti-HSA, PE anti-CD8,
allophycocyanin (APC) anti-CD4, APC anti-CD8, PE anti-
TCR , and APC anti-B220 (BD PharMingen). Biotinylated an-
tibodies were visualized with streptavidin-RED613 (GIBCO
BRL). Acquisition and analysis were performed with a FACS-
Calibur™ and CELLQuest™ (Becton Dickinson). Subpopula-
tions of thymocytes and spleen cells were sorted using a FACS
Vantage™ (Becton Dickinson) and final purity was  98%.
PCR. For reverse transcription (RT)-PCR total RNA from
50,000 cells from thymus or spleen/lymph nodes was prepared
with TRIzol, primed with oligo-dT, and reverse transcribed with
Superscript II (GIBCO/BRL). RAG1 primers were 5 -CAAC-
CAAGCTGCAGACATTCTAGCACTC-3  and 5 -CAC-
GTCGATCCGGAAAATCCTGGCAATG-3 .  -actin primers
were 5 -TACCACTGGCATCGTGATGGACT-3  and 5 -TTT-
CTGCATCCTGTCGGCAAT-3 . PCR was performed at 94 C
30 s, 62 C 60 s, 72 C 45 s, for 32 cycles. VJ  genes were ampli-
fied from cDNA primed with the   chain constant region–spe-
cific primer 5 -ATCCATAGCCTTCATGTCCA-3 . PCR was
nested using a C  primer 5 -TCAAAGTCGGTGAACAG-
GCA-3  and a degenerate V  primer AGAAGGTGAAGCA-
GAGNNM as described (40) for two cycles at 94 C 30 s, 52 C 60 s,
72 C 60 s, followed by 40 cycles at 94 C 30 s, 55 C 60 s, 72 C
60 s. PCR products were cloned before sequencing. V-J  se-
quences were cloned and sequenced using the degenerate
V  primers 5 -GGMCAYAVTGCTVTKTWCTGGTA-3 , 5 -
AAYCATGAYAMMATGTACTGGTA-3 , 5 -CARGCHC-
CTTCGVTGDNYTGGTA-3 , and C  nested primers, 5 -
TCAGGCAGTAGCTATAATTGCTCTC-3 , 5 -TTGCCAT-
TCACCCACCAGCTC-3 , and 5 -GCTCAGCTCCACGTG-
GTCAG-3 . (M   A/C, R   A/G, W   A/T, Y   C/T, K  
G/T, V   A/C/G, H   A/C/T, D   A/G/T, N   A/C/G/
T). J  and V -J  segments were identified by comparison to the
GenBank/EMBL/DDBJ database sequences with accession nos.
M64239 and AE000663–5, respectively.
TCR  gene recombination was measured by PCR reactions
using the degenerate V  primer described above in conjunction
with either a proximal J  primer 5 -ACATGAGCTCACTGT-
CAGCT-3  (3  to J 24.2) or a distal J  primer 5 -TTACTTG-
GCTTCACTGTGAG-3  (3  to J 57.9; see Fig. 4). PCR was at:
94 C 30 s, 55 C 60 s, 72 C 3 min for 25 cycles. PCR products
were analyzed by electrophoresis in agarose and visualized by
blotting and hybridizing with radiolabeled J  probes 5 -AGG-
AGGGTCTGCGAAGCTCATCTTT-3  (proximal) and 5 -
ACCAATACAGGCAAATTAACCTTTG-3  (distal). For single
cell PCR, the stained cells and the cytometer sheath fluid were
treated with 0.25 pg/ml RNase A to avoid contamination with
RNA from lysed cells. Single CD25 CD44  DN T cells from
RYIIRAG1 /   and wild-type mice were sorted into 96-well
plates containing 4  l catch buffer (75 mM NaCl, 1 mM DTT, 4
units Promega RNAsin, 7 units Eppendorf Prime RNase inhib-
itor) per well and placed on dry ice. RT reactions were per-
formed by addition of 7  l of random hexamer solution (300 ng
random hexamers, 2 pmole RAG1-specific primer: 5 -CTT-
GAGTCCCCGATGGGCAGTAAA-3 , 1.4% NP-40, 10 units
Eppendorph Prime RNase inhibitor, water) followed by a 1-min
incubation at 37 C followed by addition of 14  l of RT reaction
solution (5  l of 5  first strand Superscript buffer, 1 mM dNTPs,
8 mM DTT, 14 units Promega RNAsin, 7 units Prime RNAsin,
0.5  l Superscript II [GIBCO BRL]). RT was for 10 min at
25 C, followed by 30 min at 37 C, and the enzyme was destroyed
by incubation at 90 C for 6 min. 2.5  l (10%) of the cDNA for473 Yannoutsos et al.
each cell was used for nested PCR reactions to amplify RAG1
cDNA or glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
as a positive control. The primers for both RAG1 and GAPDH
were designed to span introns to distinguish cDNA from genomic
DNA. PCR primers: RAG1 external sense: 5 -GCTATCTCT-
GTGGCATCGAGTGTT-3 ; RAG1 external antisense: 5 -AAA-
GACTTTGGGTTTTAGC-3 ; RAG1-nested-sense: 5 -GCCG-
GGAGGCCTGTGGAG-3 ; RAG1 nested antisense: 5 -CCG-
TCGGGTGGATGGAGTCAA-3 ; GAPDH external sense: 5 -
GGTCATCATCTCCGCCCCTTCTG-3 ;  GAPDH exter-
nal antisense: 5 -CACCCTGTTGCTGTAGCCGTATTC-3 ;
GAPDH nested sense: 5 -TTTGGCATTGTGGAAGGGCT-
CAT-3 ; GAPDH nested antisense: 5 -TCGAAGGTGGAAG-
AGTGGGAGTTG-3 . PCR cycle conditions were: 94 C 15 min,
40 cycles of 94 C 30 s, 55 C 30 s, 72 C 30 s, and finally a 7-min
extension at 72 C. A total of 138 cells were assayed for RAG1 ex-
pression from the RYIIRAG1 /  mice and 64 cells were assayed
from wild-type mice. To ensure that difference between
RYIIRAG1 /  and control samples was not due to the fourfold
decrease in RAG1 mRNA in RYIIRAG1 /  cells we performed
four separate PCR experiments on each RYIIRAG1 /  cell and
diluted control cell cDNA.
Quantitative Southern Blotting. Quantitative Southern blotting
was performed exactly as described using the J 19330.11,
J 42417.4, and J 4.1 probes (28).
Immunofluorescence. In situ  staining for Nijmegen breakage
syndrome (NBS)1 was as described previously (41).
Online Supplemental Data Section. The online supplemental
data contains two tables, online supplemental Tables S1 and S2.
Online supplemental material is available at http://www.jem/
org/cgi/content/full/194/4/471/DC1. 
Results
To clarify cis regulation of RAG expression in vivo we
analyzed transgenic mice carrying an 80-kb YAC contain-
ing 33 kb of genomic sequence 5  of RAG1 and 12 kb of
sequence 5  of RAG2 (RYAC; Fig. 1). The two lines re-
ported here (RYII single-copy and RYIII three-copy)
were maintained by breeding to RAG1 /  or RAG2 / 
mice and are referred to as RYIIRAG1 / , RYIIRAG2 / ,
and RYIIIRAG1 / .
RAG Expression in DN Thymocytes. To determine whether
the RYAC directs expression of RAG1 and RAG2 in
vivo we measured RAG1 mRNA levels in CD25  DN
thymocytes isolated from wild-type, RYIIRAG1 / ,
RYIIIRAG1 / , and RYIIRAG2 /  mice by flow cytom-
etry. Steady-state levels of RAG1 and RAG2 mRNA were
estimated by semiquantitative RT-PCR (Fig. 1). CD25 
DN cells isolated from RYIIRAG1 / , RYIIIRAG1 / ,
and RYIIRAG2 /  mice expressed RAG mRNA at three-
to fourfold lower levels than wild-type CD25  DN cells
(Fig. 1 B). RAG indicator expression is variegated in mice
that carry BAC transgenes similar to RYAC with a variable
fraction of developing lymphocytes expressing the indicator
transgene (22). To determine whether only a fraction of the
DN cells in RYIIRAG1 /  and RYIIIRAG1 /  mice ex-
press RAG1 we conducted single-cell PCR experiments on
purified CD44 CD25  DN thymocytes. We found that
the percentage of CD44 CD25  thymocytes expressing
RAG1 in RYIIRAG1 /  was threefold lower than in
wild-type mice (online supplemental Table S1). This heter-
ogeneity in gene expression is consistent with variegation
seen in BAC reporter mice that carry similar transgenes (22).
To determine whether the difference in RAG expression
between RYAC and wild-type mice affects TCR  re-
combination and expression we cloned and characterized
TCR  mRNAs from thymus. We find no significant dif-
ferences in TCR  V, D, or J usage and no significant dif-
ferences in the nature of the joints between RYAC and
wild-type mice (online supplemental Table S2). We con-
clude that the pattern of RAG1 and RAG2 expression in
DN thymocytes in RYAC mice resembles that found in
BAC transgenic mice and that this level of expression is
sufficient for TCR  V(D)J recombination.
RAG Expression in DP Thymocytes. To determine
whether RYAC directs regulated RAG expression in DP
thymocytes we purified these cells from RYIIRAG1 / ,
RYIIIRAG1 / , RYIIRAG2 / , and wild-type control
mice and measured steady-state levels of RAG1 and RAG2
mRNA by semiquantitative RT-PCR (Fig. 1 B). We
found that there was little RAG1 or RAG2 expression in
DP thymocytes in RYIIRAG1 / , RYIIIRAG1 / , and
RYIIRAG2 /  mice (60–120-fold less than in wild-type
mice in five experiments). Thus, RYII and RYIII trans-
genic mice resemble previously characterized BAC trans-
genic mice in that a cis element that is not contained in
RYAC is required for regulated RAG1 and RAG2 expres-
sion in DP thymocytes.
T Cell Development. To determine the physiologic con-
sequences of loss of RAG1 and RAG2 expression in DP
cells we analyzed T cell development in RYIIRAG1 / ,
Figure 1. RAG1 is expressed in DN T cells in RYAC transgenic mice.
(A) Diagrammatic representation of RYAC an 80-kb YAC containing
the RAG genes, 12 kb of genomic DNA 5  of RAG2, and 33 kb of ge-
nomic DNA 5  of RAG1. (B) RAG1 expression in FACS® purified thy-
mocyte subpopulations as measured by RT-PCR. HPRT,  CD3 , or
GAPDH were used as loading controls for normalizing mRNA. The data
shown are representative of five experiments. cDNA dilutions are indi-
cated. WT, wild-type.474 Role of RAG Reinduction in Thymocyte Development
RYIIRAG2 / , and RYIIIRAG1 /  mice. We found that
the developmental profile of DN cells in RYIIRAG1 / ,
RYIIRAG2 / , and RYIIIRAG1 /  mice was similar to
that of wild-type thymocytes but that the number of thy-
mocytes in the most mature DN subset (CD25 CD44 )
was decreased (Fig. 2 A). There was also a corresponding,
small but consistent, increase in the percentage of CD25 
CD44  T cells (the immediate precursors of CD25 
CD44 T cells; Fig. 2 A) and a fourfold decrease in the per-
centage of these cells in the S or G2/M phase of the cell cy-
cle in RYIIRAG1 /  and RYIIIRAG1 /  mice (as mea-
sured by analysis of DNA content after DAPI staining; data
not shown). The accumulation of nonproliferating CD25 
CD44  thymocytes in the transgenic mice resembles the
accumulation of these cells in RAG1 /  mice and is consis-
tent with variegated RAG expression in this stage of T cell
development (see above).
Despite the 98–99% reduction in RAG expression in
DP thymocytes, T cell development in RAG1 /  and
RAG2 /  mice appeared to be reconstituted by the
RYAC transgene as measured by the number of cells in the
thymus and spleen. In addition, CD4 and CD8 staining
profiles in the thymus and the periphery were similar for
RYIIRAG1 / , RYIIRAG2 / , or RYIIIRAG1 /  trans-
genic mice and wild-type controls (Fig. 2, B and C). How-
ever, the number of CD4 CD8  and CD4 CD8  single
positive (SP) cells was decreased two- to fourfold in
the  thymus of RYIIRAG1 / , RYIIRAG2 / , and
RYIIIRAG1 /  mice (Fig. 2 C). We conclude that T cell
development can proceed to the SP stage with only mini-
mal RAG mRNA expression in the DP compartment but
fewer SP cells are produced. To examine TCR expression
in developing T cells in RYIIRAG1 / , RYIIRAG2 / ,
and RYIIIRAG1 /  mice we stained thymocytes for ex-
Figure 2. T cell development in RAG1 / , RAG2 / , wild-type (WT), RYIIRAG1 / , RYIIRAG2 / , and RYIIIRAG1 /  mice. (A) CD44 and
CD25 staining profiles for DN thymocytes gated on CD4 CD8  HSAhigh cells. (B) CD4 and CD8 staining of splenocytes. (C) CD4 and CD8 staining of
thymocytes. (D) CD3 staining of thymocytes. All plots are representative of 2–4 experiments. Numbers show the percentage of cells in each quadrant.
The number of SP thymocytes and CD3high cells was 0.5–0.25 of wild-type controls in four separate experiments.
Figure 3. NBS1 foci on DP T cells from
RYIIRAG1 / , RAG2 / TCR  transgenic,
and wild-type mice. DP thymocytes were
stained with anti-NBS1 (green) and counter-
stained with Topro-3 (red). (A) WT, (B)
RAG2 / TCR , and (C) RYIIRAG1 / .
460–480 DP cells were examined for each
mouse strain for the presence of foci.475 Yannoutsos et al.
pression of the TCR–CD3 complex. Thymocytes can be
divided into three groups based on low, medium, and high
levels of CD3 expression. CD3low cells are the earliest DP
cells and express TCR  but not TCR , CD3med cells ex-
press TCR  but have not yet completed positive selection,
and CD3high cells have completed selection and as a re-
sult upregulate surface TCR expression. RYIIRAG1 / ,
RYIIRAG2 / , and RYIIIRAG1 /  mice showed an al-
tered distribution of CD3 expression: the majority of thy-
mocytes in these mice were CD3low whereas this is only a
minor population in the wild-type thymus (Fig. 2 D). In
addition, we found that the transgenic mice displayed a
two- to fourfold decrease in the number of CD3high cells,
which is also consistent with the decrease in the number
of SP thymocytes (Fig. 2 C, five experiments). Similar re-
sults were obtained by anti-TCR  staining (not shown).
We conclude that decreased RAG expression in DP
thymocytes in RYIIRAG1 / , RYIIRAG2 / , and
RYIIIRAG1 /  mice leads to a decrease in the number of
thymocytes expressing medium and high levels of TCR.
TCR  Recombination. The relative decrease in RAG
expression in DP thymocytes and the increase in the per-
centage of CD3low cells in RYAC mice suggest that there
might be lower levels of TCR  recombination. Double
stranded DNA break intermediates created during V(D)J
recombination at the TCR  locus can be visualized in de-
veloping thymocytes by staining nuclei with antibodies to
the NBS1 protein (41). To examine the extent of V(D)J
recombination in RYIIRAG1 /  thymocytes directly, we
stained purified DP cells from these mice with antibodies to
NBS1 and compared them to RAG2 /  TCR  transgenic
and wild-type mice (Fig. 3). In agreement with previous
results, 25% of wild-type DP thymocytes had NBS1 foci.
These foci were not detectable in RAG2 /  TCR  mice,
which have normal number of DP cells but do not undergo
V(D)J recombination (21). In contrast, 5% of the DP thy-
mocytes from RYIIRAG1 /  mice showed NBS1 foci.
Thus, the percentage of DP thymocytes with double
stranded breaks in RYIIRAG1 /  mice is decreased in a
manner consistent with impaired TCR  recombination.
To determine whether the TCR  genes expressed in
RYAC transgenic mice differ from the wild-type controls
we amplified and sequenced TCR  mRNAs from thymus
and spleen (Fig. 4 A). Although the V  genes expressed in
RYIIRAG1 /  mice and the VJ  junctions were indistin-
guishable from controls, the J s used in these mice were
highly biased to the proximal end of the J  cluster (Fig. 4
A, and not shown). Whereas only 8% of the wild-type
TCR  genes in the thymus used a J  from the proximal 10
kb of this cluster, 41% of the TCR  expressed in the
RYIIRAG1 /  thymus used these 5  most proximal J s
(42; Fig. 4 A). Further, in wild-type mice 42% of the J s
were from the distal half of the locus whereas only 7% of
the TCR  genes expressed in RYIIRAG1 /  mice carry
J s from the distal part of the locus (42; Fig. 4 A). Proximal
skewing of the J s was even more evident in T cells that
had undergone selection and been exported to the spleen.
In the wild-type, 75% of spleen T cells expressed TCR s
using distal J s whereas only 3% of the TCR s cloned
from RYII spleen T cells used distal J s (Fig. 4 A). We
conclude that the TCR  genes expressed in RYIIRAG1 / 
mice are highly biased toward proximal J  usage.
To determine whether skewed J  usage is due to biased
TCR  recombination we measured recombination by
PCR using primers specific for the 5  and 3  ends of the J 
locus. Both V  to 5  J  and V  to 3  J  rearrangements
were readily detected in wild-type mice but only V  to
5  J  rearrangements were found in RYIIRAG1 /  and
RYIIRAG2 /  mice (Fig. 4 B). Thus, there appears to be
a relative absence of recombination to the 3  J  locus
Figure 4. 5  skewed J  usage in RYIIRAG1 /  and RYIIRAG2 / 
mice. (A) Percentage of TCR  mRNAs using J s found within the indi-
cated 10-kb intervals in the J  locus. The results represent 68
RYIIRAG1 /  and 24 wild-type (WT) clones from the thymus, and 33
RYIIRAG1 /  and 36 WT clones from the spleen. Schematic represen-
tation of the J  locus is shown and position of J s from GenBank/
EMBL/DDBJ accession no. M64239 with distances in kbs, the position
of the PCR primers and probes used in B is shown. (B) V-J  rearrange-
ment measured by PCR on genomic DNA from total thymus. RAG1 / 
mouse tail DNA was used as a negative control. The first lane in each case
represents  60 ng of template DNA diluted as shown. PCR on CD14
was used as loading control. Results are representative of two separate ex-
periments with individual mouse samples.476 Role of RAG Reinduction in Thymocyte Development
in RYIIRAG1 /  and RYIIRAG2 /  mice. We used
Southern blotting on DNA purified from CD3low, med, high
thymocytes with probes that hybridize to the 5 , middle,
and 3  ends of the J  cluster to measure TCR  recombina-
tion directly (28). The amount of recombination was stan-
dardized with a C  probe and quantified by phosphor-
imager analysis (Fig. 5). Overall, RYIIRAG1 /  and
RYIIIRAG1 /  mice showed less J  recombination than
wild-type controls and almost all of the recombination was
restricted to the 5  portion of the J  cluster (Fig. 5).
Thymocytes must rearrange and express at least one
TCR  gene to become CD3med; therefore the theoretical
minimum V(D)J recombination that would allow a T cell
to become CD3med is 50%. In wild-type mice J  recombi-
nation was detected on 78–80% of the chromosomes in T
cells reaching this stage in development, indicating that
most CD3med cells have undergone more than a single
V(D)J rearrangement (34, 43–45; Fig. 5). In contrast,
CD3med thymocytes in RYIIRAG1 /  and RYIIIRAG1 / 
mice showed only 58 and 57% 5  J  recombination. Thus,
most CD3med cells in RYIIRAG1 /  and RYIIIRAG1 / 
mice have only attempted V(D)J recombination on one
chromosome.
In wild-type mice TCR  recombination may begin
with recombination to 5  J s, and 3  J  recombination
seems to increase as thymocytes progress to more mature
stages in development (28). For example, there was 70% 5 ,
29% middle, and 14% 3  J  recombination in CD3low DP
cells and this increased to 83, 51, and 19%, respectively,
in SP cells in wild-type mice (28; Fig. 5, bottom).
RYIIRAG1 /  and RYIIIRAG1 /  mice showed a more
drastic bias to 5  J   recombination in CD3low DP thy-
mocytes and there was no significant additional recombina-
tion to the middle and 3  part of the locus as thymocytes
progressed in development (Fig. 5). We conclude that
RYIIRAG1 /  and RYIIIRAG1 /  thymocytes differ
from wild-type in that they do not recombine 3  J s in the
DP compartment.
Discussion
RAG Regulation. RAG1 and RAG2 are closely linked
genes that are believed to originate from a transposon
which entered the vertebrate lineage at the time of the
evolution of jawed fish (2, 4, 5, 46–53). Expression of the
RAG nuclease is highly restricted, but the regulation of
RAG expression remains poorly defined.
In vitro analysis of cis regulation of the RAG1 promoter
revealed only nonspecific basal promoter activity (54–58).
In contrast, the RAG2 promoter displayed preferential ac-
tivity in lymphoid cell lines that was PAX5 and GATA3
dependent but the activity was not developmentally re-
stricted (59, 60). Two systems have been used to study
RAG transcription in vivo: RAG2 /  blastocyst reconsti-
tution and transgenic reporters (22, 23). In the RAG2 / 
blastocyst reconstitution experiments an 18-kb genomic
fragment extending from 9 kb upstream of the RAG2 pro-
moter to 2.4 kb downstream of the 3  UTR was able to re-
Figure 5. Quantitation of V-J  rear-
rangement by Southern blotting. CD4 
CD8 CD3low and CD3med populations
were purified from thymus by flow cytome-
try; splenic T and B cells were purified from
spleen. DNA was digested with BamHI (B)
and HindIII (H). The probes are 5 
(J 19330.11), middle (J 42417.4), 3 
(J 4.1), and C  (reference 28). Schematic
representation of the J  locus showing only
the relevant restriction sites; the position of
the J  probes is indicated with arrows. J 
hybridization to spleen B cell DNA was
used to calculate the relative loss of J  DNA
in purified T cells. The results in the table
are from one of two experiments, the varia-
tion between experiments was  5%.477 Yannoutsos et al.
constitute T cell development (23). These experiments
suggested that all of the information required for RAG reg-
ulation might be found proximal to RAG2 (23). In con-
trast, the transgenic reporter experiments showed that an
element in the genomic region 35–70 kb upstream of the
RAG2 promoter is required for RAG1 and RAG2 expres-
sion in DP T cells (22). Our results with RYAC confirm
the presence of a distal regulatory element that regulates
both RAG1 and RAG2 reinduction and also reconcile the
apparent discrepancies between the two sets of in vivo ex-
periments. The RYAC, which has only 12 kb of genomic
sequence 5  of the RAG2 promoter, resembles the 18-kb
fragment used in the RAG2 /  blastocyst system in that
both DNA fragments reconstitute the T cell compartment.
However, T cell reconstitution by RYAC occurs in ab-
sence of the second wave of RAG expression in DP T cells.
Thus, the distal element identified in the transgenic re-
porter system could not have been detected by the T cell
rescue experiments in the RAG2 /  blastocyst system.
TCR  Recombination. In wild-type mice, TCR  re-
combination is thought to proceed coordinately on both
chromosomes without allelic exclusion (34, 43–45, 61).
Only a small fraction of the TCR  genes in CD3med DP T
cells are in the germline configuration, and there is an in-
crease in the amount of 3  J  recombination as thymocytes
mature, which is consistent with continuing chromosome
loss due to continued TCR  recombination in the DP
stage (27, 29). In contrast, in RYAC mice, almost half of
the TCR  genes in CD3med DP T cells are in the germline
configuration; only 57% of the TCR  alleles are recom-
bined. All CD3med DP T cells must express a TCR  gene,
therefore 57% recombination is just over the theoretical
limit of 50% required for TCR  expression in these cells.
This indicates that most CD3med transgenic T cells undergo
TCR  rearrangement on only one allele and suggests that
TCR  recombination begins on one chromosome.
The 5  portion of the TCR  locus is believed to be the
first part of the J  cluster to become available for recombi-
nation (27–29). Sterile transcription from the TEA is associ-
ated with accessibility to this part of the locus in the late
DN stage of T cell development, and in the absence of the
TEA the 5  most J s are not recombined (30, 31). The 3 
portion of the J  cluster is thought to become accessible for
recombination later in T cell development in a TEA-inde-
pendent but TCR  enhancer–dependent fashion (26, 62–
64). Thus, the 5  J   recombination we find in RYAC
transgenic mice might be accounted for by residual RAG
protein in thymocytes transiting from the DN to the DP
stage and the absence of 3  J  recombination due to the rel-
ative lack of RAG expression in DP thymocytes. Alterna-
tively, the 1–2% of normal levels of RAG expression we
find in DP T cells could be enough to recombine only 5  J 
genes. In either case, the finding that only the 5  J  genes
are rearranged in the absence of the normal second wave of
RAG expression clearly demonstrates that TCR  recombi-
nation is ordered, and that the 5  side of the J  cluster is the
first to become accessible to the recombinase (27–30).
The second wave of RAG expression in DP thymocytes
is normally terminated during positive selection (20, 32, 33,
65). Transgenic and gene targeted mice that carry nonse-
lecting receptors undergo persistent TCR  locus secondary
recombination (33, 36, 37). Additional support for the idea
that there is continuing recombination in DP thymocytes
comes from the finding that 3  J  rearrangements accumu-
late as normal thymocytes progress to the mature SP stage
(28, 37). RYAC transgenic thymocytes fail to activate the
second wave of RAG expression and fail to accumulate 3 
J  rearrangements that are indicative of secondary recom-
bination. Despite this 5  bias and apparent absence of con-
tinued V(D)J recombination, mature RYAC thymocytes
show higher levels of J  chromosome loss than immature
CD3low DP thymocytes. We cannot rule out the possibility
that the 1–2% of normal level RAG expression in RYAC
DP thymocytes targets continuing 5  J  but not 3  J  re-
combination, but this seems unlikely. It seems more likely
that the increase in chromosome loss in mature T cells in
RYAC mice simply reflects selection for the few T cells
that have randomly recombined both TCR  alleles be-
cause these cells have a higher probability of producing an
in frame TCR  gene.
By comparing TCR  recombination in wild-type mice
with RYAC transgenic mice that do not reinduce RAG
expression, we can estimate the contribution of secondary
TCR  recombination to the normal  /  T cell repertoire.
Less than 10% of all TCR  genes expressed in mature
RYAC T cells contain J s from the 3  half of the J  clus-
ter. In contrast, 75% of all TCR  genes expressed by
splenic T cells in wild-type mice carry J s from the 3  half
of the J  cluster. Thus, at least 65% of the TCR  genes in
wild-type mice appear to be products of secondary recom-
bination, a much higher level than the 25% estimated for
Ig  receptor editing in B cells (66). We conclude that the
majority of the TCR  repertoire in the spleen of wild-type
mice is the product of secondary V(D)J recombination and
that secondary recombination makes a major contribution
to the normal  /  TCR repertoire.
It has been proposed that  /  T cells are the evolution-
ary precursors of    T cells (67). The V(D)J recombination
in RYAC  /  T cells is developmentally similar to that of
the  /  cells in that it is mostly absent in the DP compart-
ment. Unlike  /  T cells, in which the rearrangement is
not ordered and shows no allelic exclusion (68), the simple
pattern of rearrangement in RYAC  /  T cells results in
virtual allelic exclusion of the TCR  locus. It leads, how-
ever, to a two- to threefold decrease in the number of SP
thymocytes and a substantial decrease in the complexity of
the  /  T cell receptor repertoire, as only a fraction of the
available J s are used. We speculate that the cis regulatory
element that induces the second wave of RAG expression
is a late addition to the RAG locus that was selected in
evolution at the expense of allelic exclusion because this el-
ement increased the diversity of the repertoire.
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